Clinical TrialsSearch results
Number of results: 551
Recruiting
- A research study comparing how well different doses of the medicine NNC0519-0130 lower blood sugar in people with type 2 diabetes
- Type 2 diabetes
- Takase Juri
- 2024-03-15
Recruiting
- A Research Study to See How Switching from a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults with Type 2 Diabetes
- Type 2 Diabetes
- Tsukasaki Nobuaki
- 2024-04-12
Recruiting
- A research study to see how well new weekly medicine IcoSema, which is a combination of insulin icodec and semaglutide, controls blood sugar levels in people with type 2 diabetes, compared to daily insulin glargine(NN1535-4988:COMBINE 4)
- Type 2 diabetes
- takizaki Hiroshi
- 2024-01-26
Other
- Glycemic control and Oxidative stress with Glimepiride or Nateglinide alone in type 2 OHA naive diabetic patients.
- type 2 diabetes
- Tokyo Medical University The 3rd Department of Internal Medicine
- 2007-05-30
Other
- Primary prevention of cerebrovascular and cardiovascular events with an oral antidiabetic agent in patients with type 2 diabetes at high risk for cerebral infarction
- Type 2 Diabetes
- PROFIT-J Study Steering Committee
- 2007-10-09
Recruiting
- Outcomes of trigger finger corticosteroid injection with and without anesthetic
- Trigger finger
- Fukumoto Keizo
- 2023-05-26
Other
- Therapeutic Strategy for Severe Head Trauma Patients with Mild Hypothermia and Estimation of Medical Expenses in Japan.
- Traumatic Brain Injuries
- BHYPO Group
- 2005-09-13
Other
- A prospective, multicentre, observational trial for hemodynamic reaction following initial fluid resuscitation in patients with hemorrhagic shock due to blunt trauma
- Trauma patients with hemorrhagic shock
- The General Planning Committee of Japanese Association for the Surgery of Trauma
- 2008-03-07
Other
- Therapeutic exploratory study of KCB-1B for patients with tibial shaft fracture
- Tibial shaft fracture
- Kaken Pharmaceutical Co.,Ltd.
- 2007-10-11
Other
- Phase II study of amrubicin combined with carboplatin for unresectable invasive thymoma or thymic carcinoma
- Thymoma/Thymic carcinoma
- Tohoku University Hospital
- 2010-03-31